芬用于治疗癌症的新用途
Runan Zuo1,2, Xinyi Guo1,3, Xinhao Song1
1Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China.
黄 (HF) 通过抑制癌细胞增殖,转移和入侵,显示出显著的抗癌作用. 本综述详细介绍了其分子机制以及临床癌症治疗的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 基 (Halofuginone,简称HF) 是一种小分子类化合物,由基 (febrifugine) 衍生,具有多种生物活性.
- 在治疗寄生虫感染,纤维化和自身免疫性疾病方面,高血压已经显示出前景.
- 新兴的研究突出显示了HF强大的抗癌特性.
研究的目的:
- 审查halofuginone (HF) 的抗癌作用.
- 阐明HF抗癌活性背后的分子机制.
- 评估HF在临床癌症治疗中的治疗潜力.
主要方法:
- 对研究HF抗癌效应的文献综述.
- 对HF准的分子通路的分析,包括TGF-β/Smad-3/Nrf2,Akt/mTORC1/Wnt/β-catenin,以及miR-31/HDAC2.2.
- 检查HF与瘤微环境 (TME),细胞外基质 (ECM) 和免疫细胞的相互作用.
主要成果:
- 高频抑制癌细胞的增殖,粘附,转移和入侵.
- 关键的分子机制包括对TGF-β,Akt,mtORC1,Wnt/β-catenin,miR-31和HDAC2通路的调节.
- HF作为一种依赖ATP的抑制剂,影响核糖体形成和TME,特别是与ProRS和AAS疗法结合使用时.
结论:
- 黄具有作为抗癌剂的显著潜力.
- HF的多方面的分子机制提供了一个有前途的治疗策略.
- 涉及HF的组合疗法需要进一步研究以提高临床疗效.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Drugs that Stabilize Microtubules
